Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CRON
CRON logo

CRON Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cronos Group Inc (CRON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.520
1 Day change
52 Week Range
3.430
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cronos Group Inc (CRON) is not a strong buy at the moment for a long-term beginner investor with $50,000-$100,000 to invest. While the company has shown revenue growth, its declining net income and EPS, coupled with neutral trading sentiment and lack of recent positive news or catalysts, suggest that it is better to hold off on investing until more favorable conditions emerge.

Technical Analysis

The MACD is negatively expanding, indicating a bearish trend. RSI is neutral at 33.052, and moving averages are converging, showing no clear momentum. The stock is trading near its support level of 2.569, but there is no strong technical signal for a reversal or breakout.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low Put-Call ratio indicates a bullish sentiment in open interest, but the option volume ratio is more balanced, suggesting mixed sentiment among traders.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
5

Positive Catalysts

  • Analysts have initiated coverage with 'Buy' ratings and price targets of C$4.25 and C$4.50, citing strong Canadian cannabis brands and potential profitability improvements.

Neutral/Negative Catalysts

  • Net income and EPS have significantly declined in the latest quarter. The MACD indicates a bearish trend, and there is no recent news or significant trading activity by insiders, hedge funds, or Congress to act as a positive catalyst.

Financial Performance

In Q4 2025, revenue increased by 46.96% YoY to $44.53M, but net income dropped by -104.15% YoY to -$1.82M. EPS fell to 0, down -100% YoY. Gross margin improved slightly to 35.45%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts from TD Securities and Canaccord have initiated 'Buy' ratings with price targets of C$4.25-C$4.50, citing strong market positioning and potential for transformational growth.

Wall Street analysts forecast CRON stock price to rise
2 Analyst Rating
Wall Street analysts forecast CRON stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.520
sliders
Low
2.3
Averages
2.72
High
3.14
Current: 2.520
sliders
Low
2.3
Averages
2.72
High
3.14
TD Securities
NULL -> Buy
initiated
$4.50
AI Analysis
2026-02-24
Reason
TD Securities
Price Target
$4.50
AI Analysis
2026-02-24
initiated
NULL -> Buy
Reason
TD Securities initiated coverage of Cronos Group with a Buy rating and C$4.50 price target. Cronos, which has "some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Canaccord
Kenric Tyghe
Buy
initiated
$4.25
2026-01-27
Reason
Canaccord
Kenric Tyghe
Price Target
$4.25
2026-01-27
initiated
Buy
Reason
Canaccord analyst Kenric Tyghe initiated coverage of Cronos Group with a Buy rating and C$4.25 price target. While Canada and Israel are the company's two largest markets today, the firm believes that its recent acquisition of CanAdelaar and the expansion of Cronos Growing Company are "the leading edge of transformational change at the company," the analyst tells investors in a note starting coverage of the the Canadian cannabis group.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRON
Unlock Now

People Also Watch